CytomX Therapeutics, Inc. (CTMX)
5.66
+0.22
(+4.04%)
USD |
NASDAQ |
Feb 25, 10:40
CytomX Therapeutics Shareholders Equity (Annual) : -0.456M for Dec. 31, 2024
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| REGENXBIO, Inc. | 259.65M |
| ACADIA Pharmaceuticals, Inc. | 732.79M |
| Alnylam Pharmaceuticals, Inc. | 789.18M |
| Savara, Inc. | 171.45M |
| BioMarin Pharmaceutical, Inc. | 6.087B |